Photo from Aaron Goodman/X
Aug 12, 2023, 16:19
Aaron Goodman: LOTIS-9 Trial in diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities
In a post on Twitter by Aaron Goodman, Hematologist/Bone Marrow Transplanter at UCSD, it says, “diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities
Another drug that was FDA approved on single arm data. Looks like it’s toxic. Maybe should come off market.”
For the article click here
Source:Aaron Goodman / Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46